Market Indices
Sector Heatmap
CELC — Celcuity Inc. Common Stock
NasdaqCelcuity Inc. Common Stock
- O
- 75.21
- H
- 75.44
- L
- 70.68
- V
- 1.39M
CELC — Latest News & Headlines
18 StoriesIs Celcuity (CELC) Stock a Buy? - Yahoo Finance
Is Celcuity (CELC) Stock a Buy? Yahoo Finance
A ninth director joins Celcuity (CELC) with over 35 years of life sciences leadership experience. - stocktitan.net
A ninth director joins Celcuity (CELC) with over 35 years of life sciences leadership experience. stocktitan.net
How REVTORPYK Launch Will Impact Celcuity (CELC) Investors - Simply Wall Street
How REVTORPYK Launch Will Impact Celcuity (CELC) Investors Simply Wall Street
Liquidity Mapping Around (CELC) Price Events - news.stocktradersdaily.com
Liquidity Mapping Around (CELC) Price Events news.stocktradersdaily.com
Celcuity (CELC) Dropped, So What Is Behind Its Latest Move? - Yahoo Finance
Celcuity (CELC) Dropped, So What Is Behind Its Latest Move? Yahoo Finance
Why Celcuity Stock Was a Winner on Wednesday - The Motley Fool
Why Celcuity Stock Was a Winner on Wednesday The Motley Fool
Why Celcuity Stock Was a Winner on Wednesday - The Globe and Mail
Why Celcuity Stock Was a Winner on Wednesday The Globe and Mail
GTLB Stock In Spotlight After-Hours On AI-Focused Layoffs And Earnings Beat - Stocktwits
GTLB Stock In Spotlight After-Hours On AI-Focused Layoffs And Earnings Beat Stocktwits
Needham Maintains Celcuity(CELC.US) With Buy Rating, Cuts Target Price to $134 - Moomoo
Needham Maintains Celcuity(CELC.US) With Buy Rating, Cuts Target Price to $134 Moomoo
Needham maintains Buy rating on Celcuity, $134 price target - TradingView
Needham maintains Buy rating on Celcuity, $134 price target TradingView
Celcuity appoints David Gryska to board of directors By Investing.com - Investing.com Nigeria
Celcuity appoints David Gryska to board of directors By Investing.com Investing.com Nigeria
Core Biotech Trades For Wednesday (NASDAQ:CELC) - Seeking Alpha
Core Biotech Trades For Wednesday (NASDAQ:CELC) Seeking Alpha
Top Odyssey Therapeutics (ODTX) Competitors 2026 - MarketBeat
Top Odyssey Therapeutics (ODTX) Competitors 2026 MarketBeat
Is Celcuity (CELC) Cheap After Its REVTORPYK Launch? - Simply Wall Street
Is Celcuity (CELC) Cheap After Its REVTORPYK Launch? Simply Wall Street
Celcuity launches REVTORPYK for advanced breast cancer - TipRanks
Celcuity launches REVTORPYK for advanced breast cancer TipRanks
Celcuity Plunges as Narrow Cancer Drug Launch Spooks Wall Street - TipRanks
Celcuity Plunges as Narrow Cancer Drug Launch Spooks Wall Street TipRanks
Celcuity Slides As New Cancer Drug Debut Disappoints - TipRanks
Celcuity Slides As New Cancer Drug Debut Disappoints TipRanks
Celcuity adds seasoned director amid oncology commercialization push - TipRanks
Celcuity adds seasoned director amid oncology commercialization push TipRanks